Detalles de la búsqueda
1.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236702
2.
NCCN Policy Summit: Cancer Across Geography.
J Natl Compr Canc Netw
; : 1-5, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821107
3.
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 24(2): 162-174, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623515
4.
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
Support Care Cancer
; 31(12): 637, 2023 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37847317
5.
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
Breast Cancer Res Treat
; 193(1): 95-103, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35212906
6.
Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study.
Cancer Causes Control
; 33(9): 1193-1205, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35829828
7.
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
Proc Natl Acad Sci U S A
; 113(45): 12780-12785, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27791177
8.
HER2-targeted therapy for early-stage breast cancer: a comprehensive review.
Oncology (Williston Park)
; 28(4): 281-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24839797
9.
Developing questions to assess and measure patients' perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study.
Clin Exp Med
; 24(1): 36, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353722
10.
Developing Questions to Assess and Measure Patients' Perceived Survival Benefit from Adjuvant Endocrine Therapy in Breast Cancer: A Mixed Methods Pilot Study.
Res Sq
; 2023 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645964
11.
Differing Experiences of Nutrition Care During Treatment Among Oncology Nurses, Providers, and Patients.
Clin J Oncol Nurs
; 27(6): 653-662, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009882
12.
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Clin Cancer Res
; 29(24): 5021-5030, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363965
13.
A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia.
J Clin Oncol
; 41(3): 590-598, 2023 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228177
14.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol
; 41(2): 198-205, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332179
15.
Patient-Reported Measures of a Breast Cancer Nurse Navigator Program in an Underserved, Rural, and Economically Disadvantaged Patient Population.
Oncol Nurs Forum
; 49(6): 532-539, 2022 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413732
16.
Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial.
JAMA Netw Open
; 5(10): e2238191, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36279134
17.
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Clin Breast Cancer
; 22(1): 32-42, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158245
18.
Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics.
Cancers (Basel)
; 13(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638368
19.
Southwest Harvest for Health: An Adapted Mentored Vegetable Gardening Intervention for Cancer Survivors.
Nutrients
; 13(7)2021 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34371829
20.
Southwest Harvest for Health: Adapting a mentored vegetable gardening intervention for cancer survivors in the southwest.
Contemp Clin Trials Commun
; 21: 100741, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33659763